Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 190

    1.

    Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias.

    Kemp EG, Harnett AN, Chatterjee S.

    Br J Ophthalmol. 2002 Jan;86(1):31-4.PMID: 11801499 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.
    3.

    Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.

    Kurli M, Finger PT.

    Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1108-14. Epub 2005 Jun 7.PMID: 15940485 [PubMed - indexed for MEDLINE]Related articles

    4.

    The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.

    Siganos CS, Kozobolis VP, Christodoulakis EV.

    Cornea. 2002 Jan;21(1):12-6. Erratum in: Cornea. 2003 Mar;22(2):189.. PMID: 11805500 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis]

    Werschnik C, Lommatzsch PK.

    Klin Monbl Augenheilkd. 1998 Jun;212(6):465-8. German. PMID: 9715467 [PubMed - indexed for MEDLINE]Related articles

    6.

    Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.

    Shields CL, Naseripour M, Shields JA.

    Am J Ophthalmol. 2002 May;133(5):601-6.PMID: 11992855 [PubMed - indexed for MEDLINE]Related articles

    7.

    Topical mitomycin following cryotherapy for treatment of recurrent ocular surface melanoma.

    Rudkin AK, Muecke JS.

    Can J Ophthalmol. 2009 Oct;44(5):e41. No abstract available. PMID: 19798814 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]

    Groh MJ, Holbach LM, Kühnel B, Conway RM, Naumann GO.

    Ophthalmologe. 2003 Sep;100(9):708-12. German. PMID: 14504895 [PubMed - indexed for MEDLINE]Related articles

    9.

    Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.

    Rahimi F, Alipour F, Ghazizadeh Hashemi H, Hashemian MN, Mehrdad R.

    Arch Iran Med. 2009 Jan;12(1):55-9.PMID: 19111031 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.

    Wilson MW, Hungerford JL, George SM, Madreperla SA.

    Am J Ophthalmol. 1997 Sep;124(3):303-11.PMID: 9439356 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.

    Boehm MD, Huang AJ.

    Ophthalmology. 2004 Sep;111(9):1755-61.PMID: 15350333 [PubMed - indexed for MEDLINE]Related articles

    12.

    Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.

    Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W, Srivannaboon S.

    Cornea. 2005 May;24(4):443-8.PMID: 15829803 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.

    Daniell M, Maini R, Tole D.

    Clin Experiment Ophthalmol. 2002 Apr;30(2):94-8.PMID: 11886411 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery.

    Oguz H, Basar E, Gurler B.

    Acta Ophthalmol Scand. 1999 Apr;77(2):147-50.PMID: 10321528 [PubMed - indexed for MEDLINE]Related articles

    15.

    Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.

    Finger PT, Czechonska G, Liarikos S.

    Br J Ophthalmol. 1998 May;82(5):476-9.PMID: 9713051 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]

    Cartsburg O, Kersten A, Sundmacher R, Nadjari B, Pomjanski N, Böcking A.

    Klin Monbl Augenheilkd. 2001 Jun;218(6):429-34. German. PMID: 11488009 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.

    Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Pe'er J, Savir H, Holland EJ, Meisler DM, Foster JA, Folberg R, Rozenman Y.

    Ophthalmology. 1997 Dec;104(12):2085-93.PMID: 9400769 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.

    Ballalai PL, Erwenne CM, Martins MC, Lowen MS, Barros JN.

    Ophthal Plast Reconstr Surg. 2009 Jul-Aug;25(4):296-9.PMID: 19617789 [PubMed - indexed for MEDLINE]Related articles

    19.

    Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.

    Akpek EK, Ertoy D, Kalayci D, Hasiripi H.

    Cornea. 1999 Jan;18(1):59-62.PMID: 9894938 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium.

    Helal M, Messiha N, Amayem A, el-Maghraby A, Elsherif Z, Dabees M.

    Ophthalmic Surg Lasers. 1996 Aug;27(8):674-8.PMID: 8858633 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data